Literature DB >> 12460926

AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor.

Elena Puccetti1, Darja Obradovic, Tim Beissert, Andrea Bianchini, Birgit Washburn, Ferdinando Chiaradonna, Simone Boehrer, Dieter Hoelzer, Oliver Gerhard Ottmann, Pier Giuseppe Pelicci, Clara Nervi, Martin Ruthardt.   

Abstract

Acute myeloid leukemia (AML)-associated chromosomal translocations result in formation of chimeric transcription factors, such as PML/RARalpha, PLZF/RARalpha, and AML-1/ETO, of which the components are involved in regulation of transcription by chromatin modeling through histone acetylation/deacetylation. The leukemic differentiation block is attributed to deregulated transcription caused by these chimeric fusion proteins, which aberrantly recruit histone-deacetylase (HDAC) activity. One essential differentiation pathway blocked by the leukemic fusion proteins is the vitamin (Vit) D(3) signaling. Here we investigated the mechanisms by which the leukemic fusion proteins interfere with VitD(3)-induced differentiation. The VitD(3)-receptor (VDR) is, like the retinoid receptors RAR, retinoid X receptor, and the thyroid hormone receptor (TR), a ligand-inducible transcription factor. In the absence of ligand, the transcriptional activity of TR and RAR is silenced by recruitment of HDAC activity through binding to corepressors. In the presence of ligand, TR and RAR activate transcription by releasing HDAC activity and by recruiting histone-acetyltransferase activity. Here we report that VDR binds corepressors in a ligand-dependent manner and that inhibition of HDAC activity increases VitD(3) sensitivity of HL-60 cells. Nevertheless, the inhibition of HDAC activity is unable to overcome the block of VitD(3)-induced differentiation caused by PLZF/RARalpha expression. Here we demonstrate that the expression of the translocation products PML/RARalpha and PLZF/RARalpha impairs the localization of VDR in the nucleus by binding to VDR. Furthermore, the overexpression of VDR in U937 cells expressing AML-related translocation products completely abolishes the block of VitD(3)-induced differentiation. Taken together these data indicate that the AML-associated translocation products block differentiation not only by interfering with chromatin-modeling but also by sequestering factors involved in the differentiation signaling pathways, such as VDR in the VitD(3)-induced differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460926

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Novel human BTB/POZ domain-containing zinc finger protein ZBTB1 inhibits transcriptional activities of CRE.

Authors:  Qingmei Liu; Feng Yao; Minghua Wang; Bin Zhou; Hongxia Cheng; Weiping Wang; Li Jin; Qiang Lin; Jiu-Cun Wang
Journal:  Mol Cell Biochem       Date:  2011-06-25       Impact factor: 3.396

Review 2.  Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.

Authors:  John T Pinto; Jeong-In Lee; Raghu Sinha; Melanie E MacEwan; Arthur J L Cooper
Journal:  Amino Acids       Date:  2010-04-10       Impact factor: 3.520

3.  Genetic manipulation of AML1-ETO-induced expansion of hematopoietic precursors in a Drosophila model.

Authors:  Sergey A Sinenko; Tony Hung; Tatiana Moroz; Quynh-Minh Tran; Sohrab Sidhu; Matthew D Cheney; Nancy A Speck; Utpal Banerjee
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

4.  Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells.

Authors:  Annette Romanski; Kerstin Schwarz; Maren Keller; Sarah Wietbrauk; Anja Vogel; Jessica Roos; Claudia Oancea; Boris Brill; Oliver H Krämer; Hubert Serve; Martin Ruthardt; Gesine Bug
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

5.  A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.

Authors:  V Bhattacharjee; Y Zhou; T J Yen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  Activation of transcriptional activity of HSE by a novel mouse zinc finger protein ZNFD specifically expressed in testis.

Authors:  Fengqin Xu; Weiping Wang; Chen Lei; Qingmei Liu; Hao Qiu; Vinaydhar Muraleedharan; Bin Zhou; Hongxia Cheng; Zhongkai Huang; Weian Xu; Bichun Li; Minghua Wang
Journal:  Mol Cell Biochem       Date:  2012-01-10       Impact factor: 3.396

Review 7.  Acute promyelocytic leukaemia: novel insights into the mechanisms of cure.

Authors:  Hugues de Thé; Zhu Chen
Journal:  Nat Rev Cancer       Date:  2010-10-22       Impact factor: 60.716

Review 8.  Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.

Authors:  Philip J Hughes; Ewa Marcinkowska; Elzbieta Gocek; George P Studzinski; Geoffrey Brown
Journal:  Leuk Res       Date:  2009-10-06       Impact factor: 3.156

9.  Impaired Vitamin D Signaling in T Cells From a Family With Hereditary Vitamin D Resistant Rickets.

Authors:  Fatima A H Al-Jaberi; Martin Kongsbak-Wismann; Alejandro Aguayo-Orozco; Nicolai Krogh; Terkild B Buus; Daniel V Lopez; Anna K O Rode; Eva Gravesen; Klaus Olgaard; Søren Brunak; Anders Woetmann; Niels Ødum; Charlotte M Bonefeld; Carsten Geisler
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

10.  Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.

Authors:  Sabine Beez; Philipp Demmer; Elena Puccetti
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.